Skip to content

Bariendo

7 viewers · 30d

Total raised

$11.1M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $11.1M
ROUNDS
1
INVESTORS
21
FOUNDED
2023
HQ
San Francisco, CA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
7

AI overview

Updated

Bariendo Inc. is a pioneering healthcare company based in San Francisco, California, that specializes in innovative, non-surgical weight loss solutions aimed at combating obesity and related metabolic conditions. Committed to enhancing accessibility, Bariendo offers cutting-edge treatments that enable patients to achieve sustainable weight loss without the risks associated with traditional bariatric surgeries.

What sets it apart

Bariendo distinguishes itself by offering minimally invasive procedures that allow for faster recovery, fewer complications, and long-term weight loss effectiveness compared to conventional surgical options.

Funding history

1 round
EquityMar 26, 2025
Form D
+$11.1M$11.1M total

Latest SEC filings

via EDGAR · CIK 0002054636
Form D · Mar 26, 2025View on EDGAR

Products

1 tracked

ESG Stomach Tightening Procedure

Weight loss procedure

The ESG Stomach Tightening procedure, formally known as Endoscopic Sleeve Gastroplasty, is an FDA-approved non-surgical intervention that significantly reduces the stomach size by 60-75% using endoscopically placed sutures. This procedure enables patients to attain substantial weight loss, averaging 18% of their total body weight, with results that are demonstrated to last for at least five years.

  • Non-surgical and minimally invasive
  • FDA-approved procedure
  • Significant reduction in stomach size (60-75%)
  • Long-lasting results (minimum five years)